Carmell Therapeutics Issued Canada Patent to Support Plasma-based Materials

Carmell Therapeutics increased its IP portfolio with the issuance of Canada Patent No. 2,701,187, addressing Methods and Apparatus for Manufacturing Plasma Based Plastics.

The company is launching a Phase III clinical study for Bone Healing Accelerant, its first Plasma-based Bioactive Material (PBM)...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us